We are live on ! Find out more
EFM

E Fund Management Portfolio holdings

AUM $4.46B
This Fund
S&P 500
This Quarter Est. Return
+29.65%
1 Year Est. Return
–
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$1.58B
AUM Growth
+$264M
Cap. Flow
-$56.9M
Cap. Flow %
-3.61%
Top 10 Hldgs %
70.28%
Holding
330
New
38
Increased
107
Reduced
155
Closed
24

Top Buys

Rank Stock Value
1
JOYY
JOYY Inc
JOYY
+$3.5M
2
WB icon
Weibo
WB
+$2.7M
3
IVV icon
iShares Core S&P 500 ETF
IVV
+$1.76M
4
HSAI
Hesai Group
HSAI
+$1.67M
5
GPCR icon
Structure Therapeutics
GPCR
+$1.64M

Top Sells

Rank Stock Value
1
STAA icon
STAAR Surgical
STAA
+$23.4M
2
YUMC icon
Yum China
YUMC
+$14M
3
TSM icon
TSMC
TSM
+$8.84M
4
PDD icon
Pinduoduo
PDD
+$8.79M
5
AAPL icon
Apple
AAPL
+$4.77M

Sector Composition

Rank Sector Weight
1 Consumer Discretionary 50.26%
2 Technology 23.48%
3 Communication Services 8.85%
4 Real Estate 5.2%
5 Healthcare 4.53%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
BPMC
126
DELISTED
Blueprint Medicines
BPMC
$599K 0.04%
6,493
-2,072
-24% -$134K
CAMT icon
127
Camtek
CAMT
$6.34B
$599K 0.04%
+8,627
New +$525K
ARWR icon
128
Arrowhead Research
ARWR
$12B
$598K 0.04%
19,531
+4,238
+28% +$113K
BBIO icon
129
BridgeBio Pharma
BBIO
$15.1B
$596K 0.04%
14,769
-1,326
-8% -$39.8K
ABNB icon
130
Airbnb
ABNB
$112B
$593K 0.04%
4,354
-334
-7% -$43.1K
CRSP icon
131
CRISPR Therapeutics
CRSP
$5.58B
$592K 0.04%
9,460
+303
+3% +$16.8K
MRK icon
132
Merck
MRK
$364B
$587K 0.04%
5,388
+616
+13% +$63.9K
MNST icon
133
Monster Beverage
MNST
$91.5B
$574K 0.04%
19,920
-2,164
-10% -$57.8K
RARE icon
134
Ultragenyx Pharmaceutical
RARE
$2.55B
$568K 0.04%
11,871
+2,467
+26% +$95.6K
AKRO
135
DELISTED
Akero Therapeutics
AKRO
$564K 0.04%
24,172
+14,744
+156% +$291K
RVMD icon
136
Revolution Medicines
RVMD
$44.5B
$560K 0.04%
19,532
+7,877
+68% +$189K
ORLY icon
137
O'Reilly Automotive
ORLY
$71B
$560K 0.04%
8,835
-1,125
-11% -$71.1K
KRYS icon
138
Krystal Biotech
KRYS
$10.4B
$558K 0.04%
4,495
+808
+22% +$89.6K
EXAS
139
DELISTED
Exact Sciences
EXAS
$549K 0.03%
7,421
+1,583
+27% +$104K
ROIV icon
140
Roivant Sciences
ROIV
$25.8B
$549K 0.03%
48,860
+12,569
+35% +$122K
CHTR icon
141
Charter Communications
CHTR
$18.2B
$548K 0.03%
1,409
-163
-10% -$66.5K
HD icon
142
Home Depot
HD
$327B
$547K 0.03%
1,577
+8
+0.5% +$2.48K
BIDU icon
143
Baidu
BIDU
$32.8B
$545K 0.03%
4,578
– –
PG icon
144
Procter & Gamble
PG
$333B
$544K 0.03%
3,715
+36
+1% +$5.33K
IOVA icon
145
Iovance Biotherapeutics
IOVA
$3.67B
$543K 0.03%
66,738
-10,112
-13% -$52.9K
ANSS
146
DELISTED
Ansys
ANSS
$540K 0.03%
1,489
-119
-7% -$35.2K
NBIX icon
147
Neurocrine Biosciences
NBIX
$15.6B
$540K 0.03%
4,096
-89
-2% -$10.2K
MDGL icon
148
Madrigal Pharmaceuticals
MDGL
$12.3B
$534K 0.03%
2,306
-21
-0.9% -$3.67K
RXRX icon
149
Recursion Pharmaceuticals
RXRX
$1.8B
$533K 0.03%
54,094
-2,638
-5% -$18.8K
INSM icon
150
Insmed
INSM
$25.8B
$532K 0.03%
17,178
+3,130
+22% +$81.2K
4 5
6
7 8

Similar funds

ACM
Advent Capital Management New York $4.46B AUM 0.73% 1-Year Est. Return
HCM
Hamlin Capital Management New York $4.45B AUM 22.95% 1-Year Est. Return
MAM
Magellan Asset Management Sydney, Australia $4.47B AUM 4.2% 1-Year Est. Return
AP
Americana Partners Houston, Texas $4.44B AUM 29.45% 1-Year Est. Return
BP
BC Partners New York $4.43B AUM 49.12% 1-Year Est. Return
WSFS
Wilmington Savings Fund Society Wilmington, Delaware $4.48B AUM 24.77% 1-Year Est. Return
AOI
Auto-Owners Insurance Lansing, Michigan $4.43B AUM 30.05% 1-Year Est. Return
WA
WestEnd Advisors Charlotte, North Carolina $4.49B AUM 19.44% 1-Year Est. Return

E Fund Management's Q4 2023 Portfolio in Review

As of Q4 2023, E Fund Management held 330 positions worth $1.58B, up 20% from $1.31B the previous quarter. Its ten largest holdings account for 70% of the portfolio.

E Fund Management withdrew a net $56.9M in Q4 2023, closing 24 positions and reducing 155 holdings. Its most notable exit was MINISO, an estimated $2.17M position sold in full.

By sector, the portfolio is most concentrated in Consumer Discretionary at 50% of assets, up from 45% a quarter earlier, followed by Technology and Communication Services.

Against the trend, E Fund Management opened a new position in Hesai Group worth $1.52M.

  • E Fund Management's largest Q4 2023 buy was Hesai Group: 170,914 shares worth $1.52M.
  • E Fund Management added most to JOYY Inc in Q4 2023, an estimated $3.5M increase.
  • E Fund Management's biggest Q4 2023 reduction was STAAR Surgical, cutting an estimated $23.4M.
  • E Fund Management fully exited MINISO in Q4 2023, selling an estimated $2.17M.
  • E Fund Management's ten largest holdings make up 70% of its $1.58B portfolio in Q4 2023.
  • E Fund Management opened 38 new positions and closed 24 in Q4 2023.
  • E Fund Management's portfolio value rose 20% quarter-over-quarter to $1.58B.

Based on E Fund Management's 13F filing for Q4 2023, filed 7 Feb 2024.